日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P-2138. Evaluation of Risk Factors for Neurological Dysfunction in Hospitalized Patients Receiving Cefepime or Piperacillin/Tazobactam

P-2138. 接受头孢吡肟或哌拉西林/他唑巴坦治疗的住院患者神经功能障碍风险因素评估

Mahajan, Abhay; Yamajala, Sai Swaroop; Mahajan, Sumeeta; Chirlikar, Girish; Kaulakis, Mare G; Perez, Catherine K; Fedor, Christopher J; Tepe, Sarah M; Ziembicki, Jenny A; Egro, Francesco M; Drwiega, Emily N; Wareham, David W; Antonelli, Massimo; Verardi, Stefano; Gill, Karan; Henriksen, Anne Santerre; Nguyen, Sean T; Scozzari, Daniel; DeWitt, Michael E; Buckley, Christopher; Jimison, Katelyn; Shukdinas, Alaina; Williamson, John C